Title: Perfluorooctanoate suppresses spheroid attachment on endometrial epithelial cells through peroxisome proliferator-activated receptor alpha and down-regulation of Wnt signaling.
Journal: Reproductive toxicology (Elmsford, N.Y.) 20131201
Title: Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replication.
Journal: Bioorganic & medicinal chemistry letters 20130901
Title: Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer.
Journal: The Journal of biological chemistry 20121102
Title: (Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties.
Journal: Journal of medicinal chemistry 20120322
Title: Development of improved PPARβ/δ inhibitors.
Journal: ChemMedChem 20120102
Title: Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ-mediated psoriasis-like skin disease in vivo.
Journal: PloS one 20120101
Title: High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
Journal: Molecular pharmacology 20111101
Title: Administration of PPARβ/δ agonist reduces copper-induced liver damage in mice: possible implications in clinical practice.
Journal: Journal of clinical biochemistry and nutrition 20110701
Title: Bezafibrate enhances proliferation and differentiation of osteoblastic MC3T3-E1 cells via AMPK and eNOS activation.
Journal: Acta pharmacologica Sinica 20110501
Title: The decreased expression of peroxisome proliferator-activated receptors delta (PPARdelta) is reversed by digoxin in the heart of diabetic rats.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20100801
Title: Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury.
Journal: The Journal of pharmacology and experimental therapeutics 20100501
Title: Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Journal: Endocrinology 20100401
Title: Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist.
Journal: Journal of medicinal chemistry 20100225
Title: Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway.
Journal: The Journal of pharmacology and experimental therapeutics 20100201
Title: Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist.
Journal: Molecular endocrinology (Baltimore, Md.)
Title: Shearer BG, et al. Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist. Mol Endocrinol. 2008 Feb;22(2):523-9. Epub 2007 Nov 1.
Title: Zhong X, et al. Bezafibrate enhances proliferation and differentiation of osteoblastic MC3T3-E1 cells via AMPK and eNOS activation. Acta Pharmacol Sin. 2011 May;32(5):591-600.
Title: Lee WJ, et al. Activation of PPARδ attenuates neurotoxicity by inhibiting lipopolysaccharide-triggered glutamate release in BV-2 microglial cells. J Cell Biochem. 2018 Feb 1.
